BioSpace News Archive

Drug Development

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis

November 9, 2020
·
13 min read
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020

Sol-Gel Technologies, a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, announced that the company will present at the following upcoming virtual investor conferences.

November 9, 2020
·
1 min read
Drug Development

First Patient Completes Three Year Enrollment in Nevakar’s Phase III CHAMP Study of NVK-002 Evaluating Low-Dose Atropine Ophthalmic Solution for the Treatment of Myopia in Children

Key Step Forward in Developing a Potential First-to-Market Pharmacologic Treatment for Myopia in Children

November 9, 2020
·
2 min read
Pharm Country

Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1

Genetic testing, educational materials and counseling offered at no charge to patients

November 9, 2020
·
6 min read
Genetown

Orchard Therapeutics to Present at Barclays Gene Editing & Gene Therapy Summit

Orchard Therapeutics, a global gene therapy leader, announced that the company is scheduled to present at the Barclays Gene Editing & Gene Therapy Summit on November 16, 2020 at 11:15 AM ET.

November 9, 2020
·
2 min read
Business

Avadel Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Update on FT218 Development Program

New market assessment dataidentifies a significant potential market expansion opportunity for once-nightly FT218beyondexisting twice-nightly sodium oxybate patients

November 9, 2020
·
15 min read
Business

Baudax Bio Reports Third Quarter 2020 Financial Results

ANJESO® Launch Underway; Over 50 Institutions have Added ANJESO to Their Formularies with Users Giving Highly Positive Feedback and Average Monthly Orders Increasing over 125% Since Launch

November 9, 2020
·
22 min read
Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases

Researchers from the Institut national de la recherche scientifique have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.

November 9, 2020
·
3 min read
Drug Development

Nkarta Announces Presentation of Preclinical Data on NKX019, Engineered NK Cell Therapy Candidate Targeting CD19, at the Annual Meeting of the Society for Immunotherapy of Cancer

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced a preclinical update on NKX019, its investigational allogeneic cancer immunotherapy that uses donor-derived natural killer (NK) cells engineered with a membrane-bound form of IL15 and a chimeric antigen receptor (CAR) targeting the CD19 antigen.

November 9, 2020
·
7 min read
Diabetes Awareness Month helps highlight the importance of regular eye care to avoid vision loss

One of the leading causes of blindness among Canadians is diabetic retinopathy, which affects as many as 749,800 people, yet early detection and treatment can reduce the risk of blindness by 95 per cent, according to the Canadian Ophthalmological Society.

November 9, 2020
·
3 min read